When should progression-free survival be used as a surrogate for overall survival in oncology? Uneven reporting of results – different definitions and methods of analysis, lack of rigour in applying methodology – make progress difficult.
OHE together with York, Manchester and Imperial have been awarded a grant from the NIHR PRP to evaluate the PSS Commissioning for Quality and Innovation (CQUIN) schemes.
